Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Leukemia | D007938 | — | C95 | — | 1 | — | — | — | 1 |
Myeloid leukemia acute | D015470 | — | C92.0 | — | 1 | — | — | — | 1 |
Myeloid leukemia | D007951 | — | C92 | — | 1 | — | — | — | 1 |
Myelodysplastic syndromes | D009190 | — | D46 | 1 | 1 | — | — | — | 1 |
Preleukemia | D011289 | — | — | 1 | 1 | — | — | — | 1 |
Syndrome | D013577 | — | — | 1 | 1 | — | — | — | 1 |
Drug common name | Doxecitine |
INN | doxecitine |
Description | Deoxycytidine is a deoxyribonucleoside, a component of deoxyribonucleic acid. It is similar to the ribonucleoside cytidine, but with one hydroxyl group removed from the C2' position.
|
Classification | Small molecule |
Drug class | H2-receptor antagonists (cimetidine type) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1 |
PDB | — |
CAS-ID | 951-77-9 |
RxCUI | — |
ChEMBL ID | CHEMBL66115 |
ChEBI ID | 15698 |
PubChem CID | 637 |
DrugBank | DB02594 |
UNII ID | 0W860991D6 (ChemIDplus, GSRS) |